Motusol Rx (Diclofenac Diethylamine)

Diclofenac inhibits the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin synthesis. By reducing prostaglandin production at the site of application, it diminishes inflammation, swelling, and the sensitisation of pain receptors, providing local analgesic and anti‑inflammatory effects.

The exact dose and frequency are determined by the prescribing clinician based on the severity of the condition, the size of the treatment area, and patient‑specific factors. Patients should follow the prescriber’s instructions and the product label carefully.

Safety in pregnancy and lactation has not been definitively established. Use is generally reserved for situations where the potential benefit outweighs any possible risk, and only under the guidance of a qualified healthcare professional.

To place an order, submit an enquiry on the Motusol Rx product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Motusol Rx delivers diclofenac diethylamine, which offers potent COX inhibition and rapid skin penetration. Compared with other topical NSAIDs such as ibuprofen or ketoprofen gels, diclofenac often provides a higher anti‑inflammatory potency, though individual response and tolerability may vary.

Store Motusol Rx at ambient temperature, preferably below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperatures. Keep out of reach of children and do not use after the expiry date.

Apply a thin layer of the gel to the affected skin area, usually 2–4 g per application, and gently rub it in until it disappears. Wash hands before and after use, and avoid contact with eyes, mucous membranes or broken skin.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, systemic NSAID‑related complications like gastrointestinal bleeding, and potential renal or hepatic impairment in susceptible patients. Immediate medical attention is required if any signs of a serious reaction appear.

Motusol Rx should be avoided in individuals with known hypersensitivity to diclofenac, other NSAIDs, or any excipients in the formulation. It is also contraindicated on open wounds, infected skin, and in patients with severe cardiovascular, renal or hepatic disease unless specifically advised by a physician.